logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Genomics
Filter

Genomics

Categories

Sectors

Locations

Exchange

AI pharma firm BenevolentAI raises $115 million in funding,欧洲最大的人工智能+新药研发公司BenevolentAI筹资1.15亿美元

AI pharma firm BenevolentAI raises $115 million in funding

Apr 18, 2018

Life Science

Hong Kong genes testing start-up Prenetics buys UK peer DNAFit to broaden consumer reach,香港Prenetics收购英国基因检测公司DNAFit,并且计划在港上市

Hong Kong genes testing start-up Prenetics buys UK peer DNAFit to broaden consumer reach

Apr 18, 2018

Life Science

Resverlogix Announces Proposed Offering of Units

Apr 17, 2018

Life Science

Qiming Venture Partners Announces Closing Of Three New Funds Totaling $1.4B, 启明创投宣布完成总计14亿美元的三项新基金

Qiming Venture Partners Announces Closing Of Three New Funds Totaling $1.4B

Apr 16, 2018

Life Science

Merck’s China Agent Gets Approval to Start Selling Rotavirus Diarrhea Vaccine,中国智飞生物代理的美国默克五价轮状病毒疫苗获中国上市审批

Merck’s China Agent Gets Approval to Start Selling Rotavirus Diarrhea Vaccine

Apr 16, 2018

Life Science

Resverlogix Announces TSX Review Update

Apr 12, 2018

Life Science

China’s AK Medical Plans to Buy British Joint Implant Maker for USD23 Mln to Expand Market,中国爱康医疗拟1.84亿收购英国企业

China’s AK Medical Plans to Buy British Joint Implant Maker for USD23 Mln to Expand Market

Apr 11, 2018

Life Science

Resverlogix Announces US$30 Million Loan Commitment Letter

Apr 11, 2018

Life Science

Mylan to buy MS drug marketing rights from Israel's Mapi Pharma,美国迈兰制药将从以色列Mapi Pharm购买多发性硬化症药品的市场开发权

Mylan to buy MS drug marketing rights from Israel’s Mapi Pharma

Apr 10, 2018

Life Science

CMB Leads $65M Series C Round In Chinese Biotech Firm Biocytogen,中国百奥赛图完成人民币4.1亿元C轮融资

CMB Leads $65M Series C Round In Chinese Biotech Firm Biocytogen

Apr 10, 2018

Life Science

China Opens First 3D Printing Center for Precision Medicine in Guangdong,中国首个精准医学3D打印中心落户广东

China Opens First 3D Printing Center for Precision Medicine in Guangdong

Mar 28, 2018

Life Science

Resverlogix Announces Two New Publications on Apabetalone in Kidney Disease

Mar 28, 2018

Life Science

Stonegate Capital Partners Initiates Coverage on Resverlogix Corp.

Mar 19, 2018

Life Science

Resverlogix Exceeds Full Enrollment for the Pivotal Phase 3 BETonMACE Clinical Trial

Mar 19, 2018

Life Science

G1 Therapeutics Unveils Positive Mid-Stage Data for Myelopreservation in SCLC Patients,美国G1 Therapeutics公布首创性Trilaciclib的临床数据

G1 Therapeutics Unveils Positive Mid-Stage Data for Myelopreservation in SCLC Patients

Mar 5, 2018

Life Science

CARsgen Completed $60 Million Pre-C Financing Framework Agreements,中国科济生物签署6000万美元Pre-C轮融资框架协议

CARsgen Completed $60 Million Pre-C Financing Framework Agreements

Mar 2, 2018

Life Science

Resverlogix Announces Sixth Positive Recommendation From Data Safety Monitoring Board For Phase 3 Study of Apabetalone

Feb 26, 2018

Life Science

WuXi STA and Regulus Announce microRNA Development and Manufacturing Collaboration,中国合全药业与美国Regulus达成microRNA研发和生产协议

WuXi STA and Regulus Announce microRNA Development and Manufacturing Collaboration

Feb 23, 2018

Life Science

  • ‹‹ Previous
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada